Has Burt Greenberg, MD received payments from drug or device companies?

Yes. Drug and device makers reported $25,864 in general payments to Burt Greenberg, MD across 92 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Burt Greenberg, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Burt Greenberg, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Burt Greenberg, MD

Plastic and Reconstructive Surgery · Great Neck, NYNPI 1427152677

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (51.9%), food and beverage and education — rather than concentrated in one kind of arrangement. Kerecis Limited accounts for 70.3% of it on its own, with 11 other manufacturers making up the rest. 2025 is the largest year on record at $20,087, more than ten times the $188 reported in 2019. Among plastic and reconstructive surgery clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$25,864in general payments, 2019–2025

Across 92 payments — averaging $281.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Kerecis Limited$18K
Acera Surgical, Inc.$6K
Organogenesis Inc.$532
AbbVie$308
Johnson & Johnson$278
Sun Pharmaceutical Industries Inc.$158
plus $464 from 6 others

$10,968in research payments, 2019–2025

Across 4 payments — averaging $2742.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Acera Surgical, Inc.$11K

What the payments were for

Consulting fees$1,8287%
Speaking & faculty fees$13,42852%
Travel & lodging$1,3025%
Food & beverage$5,10620%
Education$4,20016%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Kerecis Limited	42	$18,192
Acera Surgical, Inc.	19	$5,932
Organogenesis Inc.	6	$532
AbbVie(2 entities)	12	$308
Johnson & Johnson	3	$278
Sun Pharmaceutical Industries Inc.	3	$158
Stimlabs LLC	1	$142
Revance Therapeutics, Inc.	1	$133
Amgen	1	$93
Incyte Corporation	2	$47
Regeneron Healthcare Solutions, Inc.	1	$39
Tepha Inc	1	$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$25,864 in reported general payments places this provider in the 90th percentile of 219 plastic and reconstructive surgery providers in New York.

See all plastic and reconstructive surgery providers in New York →

Medicare billing

Part B allowed, 2024

$875,976

Medicare patients

367

Services billed

1,381

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav	242	$1,572
Methylprednisolone	178	$1,134
Acetaminophen-CodeineAcetaminophen With Codeine	154	$1,025
Ciprofloxacin Hcl	34	$210
ErythromycinErythromycin Base	11	$103
Hydromorphone Hcl	14	$71

Paid to pharmacies, not to this prescriber.

Other plastic and reconstructive surgery in Great Neck

Kevin TehraniGreat Neck$9K
Brian CohenGreat Neck$5K
Marjorie ReidGreat Neck$5K
Thomas DavenportGarden City$2.8M
Howard LangsteinRochester$350K
James BradleyNew Hyde Park$306K
David FuntWoodmere$295K
Robert GrantNew York$207K
Christine RohdeNew York$180K
Steven LevineNew York$108K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →